| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Entrepreneurialism > Business Plans - Beliefs About Lenders and Investors |
|
Just Answers - Business Plans - Beliefs About Lenders and Investors
Every business works within the context of core beliefs. We have developed beliefs that define According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product how we work with lenders and investors. We consider them to be guiding principles that, if ap ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in lied, will improve the quality of your business plan as well as the quality of your relationshi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s with others. We share them with you in this article in the hope that you will find these bel here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe efs worthy of adopting in your business as well. Belief 1: They fund people, not d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rojects. Funders are not interested in your product as much as they are in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc you. After all, you are going to manage, market, and produce products and services that easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi will earn them their return on investment. They want people in whom they can feel confident. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ockquote>Belief 2: They want to lend or invest--not give. Funders want and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ heir money to work for them to earn a return. Therefore, they expect information to be provided ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi milestones to be met, and plans to be followed. They are not giving a grant--they are investin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a g in you.Belief 3: They don't want to have to work for their return--they want dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod heir money to work for them. Funders are not interested in taking over you cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin project and making your plan work. They want you to do that. They have already worked hard to tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen arn their money. Now, they want their money to work for them.Belief 4: Asking t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel em to consider an unprepared project harms everyone. You typically get onl ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust y one chance to impress an investor. If they are presented with a poorly prepared business plan y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products they have already formed their negative opinion about you and your project. In addition, while . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de they may be missing out on a truly promising project, they likely don't believe you can pull it elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip off at this point.(c) Copyright 2006, Leonard M. Stillman Jr., All Rights Reserved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Find Some Sample Payroll Check Stubs on the Net for Easy Reference Revolutionary Approach to Customer Service I Have An Idea For A New Product, But Now What?
|